WOLFRAM SYNDROME 2
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
In humans, mutations in CISD2 result in Wolfram syndrome 2, a disease in which the patients display juvenile diabetes, neuropsychiatric disorders and defective platelet aggregation.
|
29666474 |
2019 |
WOLFRAM SYNDROME 2
|
0.900 |
Biomarker
|
disease |
BEFREE |
Strikingly, there is a ~70% decrease in Cisd2 protein, a key regulator of lifespan in mice and the disease gene for Wolfram syndrome 2 in humans, within the gastrocnemius after middle age among mice.
|
29168286 |
2018 |
WOLFRAM SYNDROME 2
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Mutations of CISD2 gene cause autosomal recessive Wolfram syndrome 2 (WS2) characterized by the absence of diabetes insipidus and psychiatric disorders, and by bleeding upper intestinal ulcer and defective platelet aggregation.
|
30171196 |
2018 |
WOLFRAM SYNDROME 2
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Mutations of CISD2 gene cause autosomal recessive Wolfram syndrome 2 (WS2) characterized by the absence of diabetes insipidus and psychiatric disorders, and by bleeding upper intestinal ulcer and defective platelet aggregation.
|
29774890 |
2018 |
WOLFRAM SYNDROME 2
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A novel CISD2 mutation associated with a classical Wolfram syndrome phenotype alters Ca2+ homeostasis and ER-mitochondria interactions.
|
28335035 |
2017 |
WOLFRAM SYNDROME 2
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
We concluded that the c.103 + 1G > A mutation resulted in the loss of functional CISD2 protein in the two Italian WFS2 patients.
|
29237418 |
2017 |
WOLFRAM SYNDROME 2
|
0.900 |
Biomarker
|
disease |
BEFREE |
Miner2 is a member of a new CDGSH iron-sulfur protein family that also includes two mitochondrial proteins: the type II diabetes-related mitoNEET and the Wolfram syndrome 2-linked Miner1.
|
28082676 |
2017 |
WOLFRAM SYNDROME 2
|
0.900 |
Biomarker
|
disease |
BEFREE |
Abnormal regulation of NEET proteins was consequently found to result in multiple health conditions, and aberrant splicing of NAF-1 was found to be a causative of the neurological genetic disorder Wolfram Syndrome 2.
|
25448035 |
2015 |
WOLFRAM SYNDROME 2
|
0.900 |
Biomarker
|
disease |
CTD_human |
Genetic studies in Drosophila and humans support a model for the concerted function of CISD2, PPT1 and CLN3 in disease.
|
24705017 |
2014 |
WOLFRAM SYNDROME 2
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A novel CISD2 intragenic deletion, optic neuropathy and platelet aggregation defect in Wolfram syndrome type 2.
|
25056293 |
2014 |
WOLFRAM SYNDROME 2
|
0.900 |
Biomarker
|
disease |
BEFREE |
Future work will examine how the CISD2 knockout mouse helps us to understand WFS2 pathogenesis, as well as exploring the potential effects of increased CISD2 expression.
|
20649540 |
2010 |
WOLFRAM SYNDROME 2
|
0.900 |
Biomarker
|
disease |
BEFREE |
CISD2, the causative gene for Wolfram syndrome 2 (WFS2), is a previously uncharacterized novel gene.
|
19717971 |
2009 |
WOLFRAM SYNDROME 2
|
0.900 |
Biomarker
|
disease |
BEFREE |
Thus, this mutant mouse provides an animal model for mechanistic investigation of Cisd2 protein function and help with a pathophysiological understanding of WFS2.
|
19451219 |
2009 |
WOLFRAM SYNDROME 2
|
0.900 |
Biomarker
|
disease |
MGD |
Thus, this mutant mouse provides an animal model for mechanistic investigation of Cisd2 protein function and help with a pathophysiological understanding of WFS2.
|
19451219 |
2009 |
WOLFRAM SYNDROME 2
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2.
|
17846994 |
2007 |
WOLFRAM SYNDROME 2
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
A homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2.
|
17846994 |
2007 |
WOLFRAM SYNDROME 2
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
WOLFRAM SYNDROME 2
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|